Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
about
Nutritional supplements for people being treated for active tuberculosisNutritional supplements for people being treated for active tuberculosisNutritional supplements for people being treated for active tuberculosisResistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosisNitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection.L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.Arginine adjunctive therapy in active tuberculosis.Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β.Nitrite produced by Mycobacterium tuberculosis in human macrophages in physiologic oxygen impacts bacterial ATP consumption and gene expression.Universal stress protein Rv2624c alters abundance of arginine and enhances intracellular survival by ATP binding in mycobacteria.Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-LesteImmunity to TB and targets for immunotherapy.An evidence-based systematic review of vitamin A by the natural standard research collaboration.Shortening the 'short-course' therapy- insights into host immunity may contribute to new treatment strategies for tuberculosis.TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course.Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis.
P2860
Q24235211-51E5D9EB-8C09-4538-8A74-2E463A2B5765Q24241196-8A6E3E50-8916-4D89-84DD-C0095AE0CE8FQ26471390-D6D47469-FFB9-4DBF-B986-39E6371E7011Q28480924-7B5AE11B-51AE-40B1-BAF3-11CE5FBDEB47Q33379254-72567A6B-5688-4E81-B260-B00D051C98FBQ34962380-8377DDB6-E660-4B66-BFC9-B7276207AC17Q35103037-BF914FAF-D073-4201-B7CA-A9CF9FF43BCEQ35783492-BCBE6A7B-8AD2-4862-9CA5-0B6AEAFCF093Q36839739-100F7450-B2DA-4509-A112-E6C4791A12E9Q37037086-051C3BFF-9F20-4293-B560-22090FD9B2E7Q37040409-023CB238-31E5-4A68-A841-81158DD3747BQ37318269-9FFEC9B8-0E97-4935-A360-B91470E171A7Q37352781-32A980DE-6AD8-4688-A9F6-5BA9899A5E2BQ37399895-7D5EC8A0-4BB0-4C69-BCE1-BF78D51B8462Q37984571-303771EA-B6EF-4B94-A168-A6D7EFFCA04BQ38060232-C44B7EC4-5933-4D06-8037-4A1B658DD2F9Q38075095-15DDA9AA-7807-44F5-808A-833D795F8860Q40439495-6F4E9FB4-610C-4561-89FC-9091A697896DQ43241985-FCA73AF6-4586-4D9F-BB40-C30A76F4CC0AQ53689606-4BE360BD-9C4F-4ED7-AD93-FC46C45920F0
P2860
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@ast
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@en
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@nl
type
label
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@ast
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@en
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@nl
prefLabel
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@ast
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@en
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@nl
P2093
P3181
P1476
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
@en
P2093
O Stendahl
T Sundqvist
P3181
P356
10.1183/09031936.03.00090702
P407
P577
2003-03-01T00:00:00Z